Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a significant increase in short interest in July. As of July 15th, there was short interest totaling 4,409 shares, an increase of 64.3% from the June 30th total of 2,684 shares. Based on an average daily trading volume, of 5,551 shares, the days-to-cover ratio is presently 0.8 days.

Cardio Diagnostics Stock Performance

Shares of Cardio Diagnostics stock traded down $0.00 during trading on Friday, reaching $0.01. The company’s stock had a trading volume of 2,500 shares, compared to its average volume of 46,002. The stock has a 50-day moving average price of $0.02 and a two-hundred day moving average price of $0.02. Cardio Diagnostics has a one year low of $0.01 and a one year high of $0.07.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.